This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. David Corey, PhD
Professor of Pharmacology and Biochemistry at UT Southwestern; Past President, OTS
Speaker

Profile

David Corey received a BA in Chemistry from Harvard University in 1985 and a PhD in Chemistry in 1990 working under the guidance of Peter Schultz. After completed postdoctoral work with Dr. Charles Craik at UCSF, David joined the Pharmacology Department at UT Southwestern Medical Center in 1992, where he is now a Professor of Pharmacology and Biochemistry. David has published over 200 papers, is Past President of the Oligonucleotide Therapeutics Society, and is an Executive Editor at Nucleic Acid Therapeutics where he handles manuscripts related to therapeutic nucleic acids.

Agenda Sessions

  • Oligonucleotide Therapeutics: Current Challenges and Opportunities

    11:00am